LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC (www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by Solazyme, Inc. (“Solazyme” or the “Company”) (NASDAQ: SZYM). The investigation focuses on whether the Company and its officers violated securities laws by allegedly concealing material information from investors.
If you purchased or otherwise acquired Solazyme shares and would like more information regarding the investigation, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr., Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.
Solazyme is a San Francisco-based bioproducts company that produces sustainable oils from microalgae. The Company uses an industrial fermentation process to transform plant-based sugars into triglyceride oils, which are used in a wide range of products. The Company is being investigated for allegedly issuing false and/or misleading statements and concealing material information concerning the production capacity of its oil producing facility in Moema, Brazil. Solazyme improperly concealed ongoing construction delays caused by inadequate access to electricity and steam utility services. The diminished capacity of Solazyme’s Brazilian oil facility was made known to the investing public on November 5, 2014, when the Company disclosed that it needed to “narrow [its] production focus to smaller volumes of higher value products.” As a result of this news, shares of Solazyme fell $4.35 per share, or 58.08 percent, to close on November 6, 2014, at $3.14 per share on heavy volume.
If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
